Table 1.

Study sponsors and test descriptions.

Study	Company	Test
1	Crescendo Biosciences	VectraDA: blood test to assess rheumatoid arthritis activity
2	Lineagen	FirstStepDX PLUS Chromosomal Microarray: high-resolution chromosomal microarray for rare disease diagnosis
3	Metamark	ProMark: multiplex immunofluorescence imaging platform analysis for aggressiveness of prostate cancer tumors
4	Applied Proteomics	SimpliPro Colon: proteomic analysis to predict likelihood of colorectal cancer